| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.05 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.074 | 0.05 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.05 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.05 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.075 | 0.05 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.06 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |